Sonic Hedgehog Expression is Associated with Lymph Node Invasion in Urothelial Bladder Cancer.


Journal

Pathology oncology research : POR
ISSN: 1532-2807
Titre abrégé: Pathol Oncol Res
Pays: Switzerland
ID NLM: 9706087

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 28 01 2018
accepted: 04 10 2018
pubmed: 27 10 2018
medline: 31 12 2019
entrez: 27 10 2018
Statut: ppublish

Résumé

Bladder cancer (BC) is a deadly disease characterized by high recurrence rates and frequent progression to an aggressive phenotype. Dysregulation of various signaling pathways have been implicated in BC tumorigenesis, however, the clinical relevance of sonic hedgehog pathway (Shh) remains under investigated. The aim of the current study was to analyze the prognostic value of Shh expression in patients with bladder carcinoma. Immunohistochemical expression of Shh was performed using tissue microarray with 128 specimens from bladder cancer patients. Kaplan-meier survival was analysed and correlation between Shh protein expression and patients' clinicopathological parameters wasexamined using Fisher's exact test. The immuno-staining results revealed that Shh protein exhibits cytoplasmic localization and is expressed in 49% of the analyzed bladder cancer cohort. Our data indicated that high Shh expression significantly correlated with increased lymph node metastasis (p = 0.02), however no association was reported between Shh expression and other clinicopatholigical parameters. High expression of sonic hedgehog was associated with lymph node invasion which may indicate that Shh might play an important role in progression and metastasis of bladder cancer.

Identifiants

pubmed: 30361899
doi: 10.1007/s12253-018-0477-6
pii: 10.1007/s12253-018-0477-6
pmc: PMC6614154
doi:

Substances chimiques

Biomarkers, Tumor 0
Hedgehog Proteins 0
SHH protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1067-1073

Subventions

Organisme : King Abdullah International Medical Research Centre
ID : SF17/001/J

Références

J Cell Physiol. 2005 May;203(2):372-7
pubmed: 15521068
Carcinogenesis. 2009 Jan;30(1):131-40
pubmed: 19028702
Cancer Res. 2016 Mar 1;76(5):1273-83
pubmed: 26676748
PLoS One. 2013;8(1):e53675
pubmed: 23308271
Tumour Biol. 2014 Mar;35(3):2817-24
pubmed: 24248542
Urol Clin North Am. 2016 Feb;43(1):47-62
pubmed: 26614028
PLoS One. 2012;7(9):e45332
pubmed: 23028941
Nat Rev Dis Primers. 2017 Apr 13;3:17022
pubmed: 28406148
Int J Cancer. 2014 Jul 1;135(1):1-6
pubmed: 23929208
Mol Carcinog. 2016 May;55(5):537-51
pubmed: 25728352
Br J Cancer. 2012 Mar 13;106(6):1177-86
pubmed: 22361633
Prostate. 2014 Aug;74(11):1142-52
pubmed: 24925370
Birth Defects Res C Embryo Today. 2006 Sep;78(3):267-79
pubmed: 17061262
Tumour Biol. 2015 Mar;36(3):2013-21
pubmed: 25387809
Biochem Biophys Res Commun. 2017 Nov 4;493(1):521-527
pubmed: 28870814
Biochim Biophys Acta. 2015 Aug;1856(1):62-72
pubmed: 26080084
Crit Rev Oncol Hematol. 2014 Jan;89(1):73-111
pubmed: 24029603
Urol Clin North Am. 2016 Feb;43(1):63-76
pubmed: 26614029
Curr Biol. 2001 May 15;11(10):769-73
pubmed: 11378387
Mol Cancer Res. 2012 Aug;10(8):995-1009
pubmed: 22714124
BMC Med. 2013 Jan 17;11:13
pubmed: 23327481
Eur Urol. 2017 Jan;71(1):96-108
pubmed: 27370177
Oncogene. 2003 May 15;22(19):2967-71
pubmed: 12771948
Nat Cell Biol. 2014 May;16(5):469-78
pubmed: 24747439
J Urol. 2000 Sep;164(3 Pt 1):680-4
pubmed: 10954628
Cancer Prev Res (Phila). 2010 Oct;3(10):1235-45
pubmed: 20858759
Lancet. 2009 Jul 18;374(9685):239-49
pubmed: 19520422
Pathol Oncol Res. 2012 Apr;18(2):349-55
pubmed: 21861243
Clin Cancer Res. 2015 Mar 1;21(5):1215-24
pubmed: 25552484
J Thorac Oncol. 2007 Jan;2(1):7-10
pubmed: 17410003
Ther Adv Med Oncol. 2010 Jul;2(4):237-50
pubmed: 21789137
Oncogene. 2014 Apr 17;33(16):2087-97
pubmed: 23686308
Cancer Res. 2012 Sep 1;72(17):4449-58
pubmed: 22815529
Urol Oncol. 2014 Jul;32(5):539-45
pubmed: 24856810
Stem Cell Res. 2015 Mar;14(2):165-76
pubmed: 25644021
Curr Opin Oncol. 2010 May;22(3):242-9
pubmed: 20150808
Genes Dev. 2001 Dec 1;15(23):3059-87
pubmed: 11731473
Curr Urol Rep. 2016 Feb;17(2):11
pubmed: 26757905
Nature. 2011 Apr 7;472(7341):110-4
pubmed: 21389986
Oncol Lett. 2011 Sep 1;2(5):995-1001
pubmed: 22866163
Can J Gastroenterol Hepatol. 2015 May;29(4):209-17
pubmed: 25965442
Carcinogenesis. 2011 Apr;32(4):445-51
pubmed: 21186299

Auteurs

Taoufik Nedjadi (T)

King Abdullah International Medical Research Centre,, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, Jeddah, Kingdom of Saudi Arabia. nedjadita@ngha.med.sa.

Nada Salem (N)

Center of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, Saudi Arabia.

Dareen Khayyat (D)

King Fahd Medical Research Centre, King Abdulaziz University, Jeddah, Saudi Arabia.

Ahmed Al-Sayyad (A)

Department of Urology, King Abdulaziz University, Jeddah, Saudi Arabia.

Adel Al-Ammari (A)

Department of Urology, King Faisal Specialist Hospital & Research Center, Jeddah, Saudi Arabia.

Jaudah Al-Maghrabi (J)

Department of Pathology, King Abdulaziz University, Jeddah, Saudi Arabia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH